Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/GA/Columbus
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Columbus, GA

Studies commonly pay $75 to $4,500 per completed study

71 clinical trials are currently recruiting participants within 30 miles of Columbus. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

71studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Columbus right now

Top 25 of 71 recruiting studies, sorted by proximity — each links to its official registry page

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

Hidradenitis Suppurativa Phase 1 Interventional 24 participants sought
Lane Dermatology and Dermatologic Surgery — Columbus, Georgia (7.3 mi) · Sponsor: Incyte Corporation

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Diabetes Mellitus, Type 2, Hypertension Phase 3 Interventional 11,800 participants sought
Centricity Research, Endocrine Consultants — Columbus, Georgia (7.3 mi) · Sponsor: Boehringer Ingelheim

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Melanoma Phase 3 Interventional 560 participants sought
John B. Amos Cancer Center — Columbus, Georgia (7.3 mi) · Sponsor: Regeneron Pharmaceuticals

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

Diabetes Mellitus, Type 1 Phase 3 Interventional 150 participants sought
Centricity Research - Columbus — Columbus, Georgia (7.3 mi) · Sponsor: vTv Therapeutics

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 500 participants sought
John B Amos Cancer Center — Columbus, Georgia (7.3 mi) · Sponsor: Bristol-Myers Squibb

A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

Triple Negative Breast Cancer Phase 3 Interventional 657 participants sought
Columbus Regional Research Institute, LLC — Columbus, Georgia (7.3 mi) · Sponsor: Jina Pharmaceuticals Inc.

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma N/A Observational 800 participants sought
John B Amos Cancer Center — Columbus, Georgia (7.3 mi) · Sponsor: University of Rochester

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

Colorectal Cancer, Sarcopenia N/A Observational 300 participants sought
John B Amos Cancer Center — Columbus, Georgia (7.3 mi) · Sponsor: Wake Forest University Health Sciences

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

High Risk Cardiovascular Disease, Hypertension Phase 3 Interventional 11,000 participants sought
Clinical Trial Site — Columbus, Georgia (7.3 mi) · Sponsor: Alnylam Pharmaceuticals

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Breast Cancer, Early Breast Cancer Phase 3 Interventional 5,500 participants sought
Research Site — Columbus, Georgia (7.3 mi) · Sponsor: AstraZeneca

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Atopic Dermatitis Phase 3 Interventional 200 participants sought
Centricity Research Columbus Dermatology /ID# 266529 — Columbus, Georgia (7.3 mi) · Sponsor: AbbVie

A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Alzheimers Disease Phase 3 Interventional 800 participants sought
Alzheimer's Research and Treatment Center - Columbus — Columbus, Georgia (7.3 mi) · Sponsor: Hoffmann-La Roche

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Non Small Cell Lung Cancer Phase 3 Interventional 780 participants sought
Centricity Research Columbus Cancer Center ( Site 0005) — Columbus, Georgia (7.3 mi) · Sponsor: Merck Sharp & Dohme LLC

Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387

Pericarditis, Pericarditis Acute Phase 2, Phase 3 Interventional 325 participants sought
Investigational Site 001 — Columbus, Georgia (7.3 mi) · Sponsor: Kiniksa Pharmaceuticals International, plc

Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

Primary Membranous Nephropathy Phase 2, Phase 3 Interventional 176 participants sought
DaVita Clinical Research Columbus — Columbus, Georgia (7.3 mi) · Sponsor: Vertex Pharmaceuticals Incorporated

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Obesity, Overweight Phase 3 Interventional 3,600 participants sought
ACCOMPLISH-1 Research Site — Columbus, Georgia (7.3 mi) · Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) Phase 3 Interventional 6,950 participants sought
Research Site — Columbus, Georgia (7.3 mi) · Sponsor: AstraZeneca

A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Advanced Non-small Cell Lung Cancer, HER2 Mutation Phase 3 Interventional 444 participants sought
John B. Amos Cancer Center — Columbus, Georgia (7.3 mi) · Sponsor: Bayer

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis Phase 2 Interventional 300 participants sought
Columbus Memory Center — Columbus, Georgia (7.3 mi) · Sponsor: Lighthouse Pharmaceuticals, Inc.

A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.

Ankle Arthrodesis or Arthroplasty, Hindfoot Fusion N/A Interventional 126 participants sought
Hughston Foundation Inc — Columbus, Georgia (7.3 mi) · Sponsor: Kuros Biosurgery AG

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Diabetes Mellitus, Type 2 Phase 3 Interventional 80 participants sought
Columbus Research Foundation — Columbus, Georgia (7.3 mi) · Sponsor: Novo Nordisk A/S
Actively enrolling

Studies you may be able to join near Columbus

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research studies for chronic kidney disease

This research platform is enrolling Black and African American adults in eligible areas who have been diagnosed with chronic kidney disease. Compensation may be available. The study team confirms eligibility before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Columbus

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Centricity Research

★ 4.7
910 Talbotton Rd, Columbus, GA 31904
(706) 321-0495
"Great people, very kind and considerate. No complaints! 😊"
— Dre Hayes, 5★

DaVita Clinical Research

★ 5.0
4 Bradley Park Ct #2b, Columbus, GA 31904
(706) 596-8222

ClinCept Clinical Research

★ 5.0
4621 River Rd, Columbus, GA 31904
(706) 780-2255
"Amazing staff always kind making sure you are in the best study for your needs. They have never failed me."
— katie eberly, 5★

Alzheimer's Research and Treatment Center Georgia

2122 Manchester Expy Ste A-002A, Columbus, GA 31904
(706) 653-8455

Metabolic Research Center | Columbus

★ 5.0 (180 reviews)
6440 W Hamilton Park Rd Suite A-103, Columbus, GA 31909
(706) 653-7888

Columbus Research Institute

★ 5.0
5820 Veterans Pkwy #304, Columbus, GA 31904
(706) 653-0419

Columbus Memory Center & Health Education Foundation

★ 3.0
7196 N Lake Dr, Columbus, GA 31909
(706) 327-4000
"My mil was diagnosed on her first visit with Alzheimer's, prescribed, sent for MRI...she progressed downhill, I called to try & move up her next appt…"
— Janice Byers, 1★

Clinical Research Institute

★ 5.0
1215 Eagles Landing Pkwy Ste. 209, Stockbridge, GA 30281
(678) 782-5358
"Loving, caring professional staff. Highly recommended. Thank you ALL 4 everything. Namaste"
— ____.pause___, 5★

Clinical Research Atlanta

★ 4.2
175 Country Club Dr #200B, Stockbridge, GA 30281
(770) 507-6867
"Great team of people and I haven't had any issues."
— Victorious Bastard, 5★

Clinical trials in Columbus: what's recruiting

The Columbus area currently has 71 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Columbus, the most active research areas are:

  • Cancer & Oncology9 studies
  • Diabetes & Metabolism5 studies
  • Heart & Vascular3 studies
  • Brain & Mental Health2 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Columbus, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Columbus

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Columbus participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Columbus pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Columbus?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Columbus, GA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
How often do new paid studies open in Columbus?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Columbus.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Columbus typically complete one or two studies per year.

Paid clinical trials near Columbus

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of GA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts